CoChat

Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury

Open access
Shein, Na'ama A., Grigoriadis, Nikolaos, Alexandrovich, Alexander G., Simeonidou, Constantina, Lourbopoulos, Athanasios, Polyzoidou, Eleni, Trembovler, Victoria, Mascagni, Paolo, A. Dinarello, Charles, Shohami, Esther · 2009 · The FASEB Journal
Cited by 98

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Despite efforts aimed at developing novel therapeutics for traumatic brain injury (TBI), no specific pharmacological agent is currently clinically available. Here, we show that the pan‐histone deacety‐ lase (HDAC) inhibitor ITF2357, a compound shown to be safe and effective in humans, improves functional recovery and attenuates tissue damage when adminis‐ tered as late as 24 h postinjury. Using a well‐character‐ ized, clinically relevant mouse model of closed head injury (CHI), we demonstrate that a single dose of ITF2357 administered 24 h postinjury improves neu‐ robehavioral recovery from d 6 up to 14 d postinjury (improved neurological score vs. vehicle; P <0.05), and that this functional benefit is accompanied by de‐ creased neuronal degeneration, reduced lesion volume (22% reduction vs. vehicle; P <0.01), and is preceded by increased acetylated histone H3 levels and attenuation of injury‐induced decreases in cytoprotective heat‐ shock protein 70 kDa and phosphorylated Akt. More‐ over, reduced glial accumulation and activation were observed 3 d postinjury, and total p53 levels at the area of injury and caspase‐3 immunoreactivity within microglia/macrophages at the trauma area were ele‐ vated, suggesting enhanced clearance of these cells via apoptosis following treatment. Hence, our find‐ ings underscore the relevance of HDAC inhibitors for ameliorating trauma‐induced functional deficits and warrant consideration of applying ITF2357 for this indication.—Shein, N. A., Grigoriadis, N., Alex‐ androvich, A. G., Simeonidou, C., Lourbopoulos, A., Polyzoidou, E., Trembovler, V., Mascagni, P., Din‐ arello, C. A., Shohami, E. Histone deacetylase inhib‐ itor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following ex‐ perimental traumatic brain injury. FASEB J. 23, 4266‐4275 (2009). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.09-134700

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Shein, N. A., Grigoriadis, N., Alexandrovich, A. G., Simeonidou, C., Lourbopoulos, A., Polyzoidou, E., Trembovler, V., Mascagni, P., A. Dinarello, C., & Shohami, E.
Venue
The FASEB Journal
Publisher
Wiley
Published
2009-09
Volume
23
Issue
12
Pages
4266-4275
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2148476252
Cited by
98
References
5
FWCI
5.81
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.